1. |
Bray F, Ferlay J, Soerjomataram I, <italic>et al</italic>. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
Chen W, Zheng R, Baade PD, <italic>et al</italic>. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
3. |
Macmahon H, Naidich DP, Goo JM, <italic>et al</italic>. Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology, 2017, 284(1): 228-243.
|
4. |
Horeweg N, Van Rosmalen J, Heuvelmans MA, <italic>et al</italic>. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol, 2014, 15(12): 1332-1341.
|
5. |
Dai C, Shen J, Ren Y, <italic>et al</italic>. Choice of surgical procedure for patients with non-small-cell lung cancer ≤ 1 cm or > 1 to 2 cm among lobectomy, segmentectomy, and wedge resection: A population-based study. J Clin Oncol, 2016, 34(26): 3175-3182.
|
6. |
Schneider BJ, Daly ME, Kennedy EB, <italic>et al</italic>. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based guideline. J Clin Oncol, 2018, 36(7): 710-719.
|
7. |
Travis WD, Brambilla E, Noguchi M, <italic>et al</italic>. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 2011, 6(2): 244-285.
|
8. |
Yu Y, Jian H, Shen L, <italic>et al</italic>. Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases. Eur J Surg Oncol, 2016, 42(11): 1714-1719.
|
9. |
Murakami S, Ito H, Tsubokawa N, <italic>et al</italic>. Prognostic value of the new IASLC/ATS/ERS classification of clinical stageⅠA lung adenocarcinoma. Lung Cancer, 2015, 90(2): 199-204.
|
10. |
Yoshiya T, Mimae T, Tsutani Y, <italic>et al</italic>. Prognostic role of subtype classification in small-sized pathologic N0 invasive lung adenocarcinoma. Ann Thorac Surg, 2016, 102(5): 1668-1673.
|
11. |
Liu S, Wang R, Zhang Y, <italic>et al</italic>. Precise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma. J Clin Oncol, 2016, 34(4): 307-313.
|
12. |
Boellaard R, Delgado-bolton R, Oyen WJ, <italic>et al</italic>. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging, 2015, 42(2): 328-354.
|
13. |
Chiu CH, Yeh YC, Lin KH, <italic>et al</italic>. Histological subtypes of lung adenocarcinoma have differential <sup>18</sup>F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan. J Thorac Oncol, 2011, 6(10): 1697-1703.
|
14. |
Nakamura H, Saji H, Shinmyo T, <italic>et al</italic>. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Lung Cancer, 2015, 87(1): 28-33.
|
15. |
Swets JA. Measuring the accuracy of diagnostic systems. Science, 1988, 240(4857): 1285-1293.
|
16. |
Lin JT, Yang XN, Zhong WZ, <italic>et al</italic>. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer. Eur J Cardiothorac Surg, 2016, 50(5): 914-919.
|
17. |
Wang S, Lin D, Yang X, <italic>et al</italic>. Clinical significance of PET/CT uptake for peripheral clinical N0 non-small cell lung cancer. Cancer Med, 2020.
|
18. |
Song CY, Kimura D, Sakai T, <italic>et al</italic>. Novel approach for predicting occult lymph node metastasis in peripheral clinical stage Ⅰ lung adenocarcinoma. J Thorac Dis, 2019, 11(4): 1410-1420.
|